RAIN News and Press, Rain Therapeutics Inc. From 10/16/23

NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of common stock of Rain for $1.25 per...

2023-10-13 17:16:44 ET More on Rain Oncology Rain Oncology Inc. (RAIN) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Rain Oncology Historical earnings data for Rain Oncology Financial information for Rain Oncology For further...

2023-08-10 18:39:03 ET Rain Oncology Inc. (RAIN) Q2 2023 Earnings Call Transcript August 10, 2023 05:00 PM ET Company Participants Dan Ferry - IR, LifeSci Advisors Avanish Vellanki - CEO Nelson Cabatuan - Acting SVP, Finance Robert Doebele - CSO Confere...

2023-08-10 16:48:26 ET Rain Oncology press release ( NASDAQ: RAIN ): Q2 GAAP EPS of -$0.61 misses by $0.12 . As of June 30, 2023, Rain had $86.3 million in cash, cash equivalents and short-term investments. Rain anticipates that its quarter-end cash position will pro...

– Evaluating a number of opportunities to diversify pipeline in precision oncology – – Submitted data abstracts for milademetan in both MANTRA and MANTRA-2 clinical studies; anticipated presentations at medical conferences in 4Q23 – – Quarter-e...

NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host ...

2023-07-07 08:29:03 ET Prestige Wealth  ( PWM ) +106% . Gorilla Technology Group  ( GRRR ) +74% Signs Contract to Deploy Massive Smart Government Project in Egypt. NuZee ( NUZE ) +51% Secures Five-Year Global Licensing Deal with Stone Brewing to...

2023-06-05 09:45:25 ET Palm Beach, FL – June 5, 2023 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it has receded. The sta...

2023-06-02 08:33:10 ET U Power ( UCAR ) +70% . Connect Biopharma Holdings  ( CNTB ) +53% Announces Positive Long-Term Data from the Maintenance Period Through Week 48 of CN002 Phase 2 Icanbelimod Trial in Patients with Moderate-to-Severe Ulcerative Colitis. ...

2023-05-30 11:02:01 ET Rain Oncology ( NASDAQ: RAIN ) shed ~9% in the morning hours Tuesday after announcing layoffs, the departure of the company’s chief medical officer, and changes to its clinical programs for lead candidate milademetan. As part of efforts to strea...